Andrew Wight
YOU?
Author Swipe
View article: Multi-centre discovery and validation study evaluating breath biomarkers for the diagnosis of lung cancer – the LuCID study
Multi-centre discovery and validation study evaluating breath biomarkers for the diagnosis of lung cancer – the LuCID study Open
Background Volatile Organic Compound (VOC) research for lung cancer detection has faced study design and analytical methodology challenges limiting translation into clinical practice. We evaluated the diagnostic value of breath biomarkers …
View article: P1.13-04 The LuCID Study: Detection of Lung Cancer Breath Biomarkers via Breath Biopsy in a Multi-Centre Trial
P1.13-04 The LuCID Study: Detection of Lung Cancer Breath Biomarkers via Breath Biopsy in a Multi-Centre Trial Open
View article: P131 The degree of acute respiratory support with COVID-19 pneumonia, smoking status on admission and non-resolving CT features at three months- are there links?
P131 The degree of acute respiratory support with COVID-19 pneumonia, smoking status on admission and non-resolving CT features at three months- are there links? Open
Introduction and Objectives BTS guidelines suggest radiological follow up at 12 weeks for patients with COVID-19 associated pneumonia. It is suggested development of post-covid fibrotic changes is more prevalent with severity of illness.
View article: P134 Health deprivation and post-COVID fibrosis: is there a relationship and what is the long-term impact?
P134 Health deprivation and post-COVID fibrosis: is there a relationship and what is the long-term impact? Open
Introduction and Objectives Health inequalities are associated with worse outcomes of COVID-19 illness.1 Health deprivation and disability is one domain within the Index of Multiple Deprivation (IMD). We investigated potential c…
View article: Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Open
SUMMARY Background Colchicine has been proposed as a treatment for COVID-19 on the basis of its anti-inflammatory actions. Methods In this randomised, controlled, open-label trial, several possible treatments were compared with usual care …
View article: Programmed death ligand 1 expression in EBUS aspirates of non–small cell lung cancer: Is interpretation affected by type of fixation?
Programmed death ligand 1 expression in EBUS aspirates of non–small cell lung cancer: Is interpretation affected by type of fixation? Open
Background Much of the reluctance about using cytology specimens rather than histology specimens to assess programmed death ligand 1 (PD‐L1) expression for guiding the use of immune modulating drugs in the management of non–small cell lung…
View article: MA13.02 PD-L1 Expression in EBUS-Guided Cytology Specimens of Non-Small Cell Lung Cancer is Not Affected by Type of Fixation: A Study of Matched Pairs
MA13.02 PD-L1 Expression in EBUS-Guided Cytology Specimens of Non-Small Cell Lung Cancer is Not Affected by Type of Fixation: A Study of Matched Pairs Open